Literature DB >> 2490853

Urinary excretion of the hydroxypyridinium cross links of collagen in patients with rheumatoid arthritis.

D Black1, M Marabani, R D Sturrock, S P Robins.   

Abstract

Values for urinary hydroxypyridinium cross links of collagen measured by high performance liquid chromatography in a group of 19 seropositive patients with rheumatoid arthritis (RA) were compared with 19 controls matched for age and sex. The amounts of pyridinoline, expressed relative to creatinine, were significantly higher in the RA group, but there was no significant increase in a bone specific analogue, deoxypyridinoline. There were significant positive correlations between pyridinoline excretion and both C reactive protein and erythrocyte sedimentation rate, whereas there was an inverse relation with grip strength. The data indicated that pyridinoline concentrations in urine are strongly associated with disease activity in patients with RA.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2490853      PMCID： PMC1003839          DOI： 10.1136/ard.48.8.641

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  12 in total

1.  Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography.

Authors:  D Black; A Duncan; S P Robins
Journal:  Anal Biochem       Date:  1988-02-15       Impact factor: 3.365

2.  Subunit composition and structure of subcomponent C1q of the first component of human complement.

Authors:  K B Reid; R R Porter
Journal:  Biochem J       Date:  1976-04-01       Impact factor: 3.857

3.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

Review 4.  Bone disease in rheumatoid arthritis.

Authors:  P N Sambrook; J Reeve
Journal:  Clin Sci (Lond)       Date:  1988-03       Impact factor: 6.124

5.  An enzyme-linked immunoassay for the collagen cross-link pyridinoline.

Authors:  S P Robins
Journal:  Biochem J       Date:  1982-12-01       Impact factor: 3.857

6.  How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?

Authors:  J T Sharp; D Y Young; G B Bluhm; A Brook; A C Brower; M Corbett; J L Decker; H K Genant; J P Gofton; N Goodman
Journal:  Arthritis Rheum       Date:  1985-12

7.  Pyridinium crosslinks of bone collagen and their location in peptides isolated from rat femur.

Authors:  S P Robins; A Duncan
Journal:  Biochim Biophys Acta       Date:  1987-08-21

8.  Measurement of the cross linking compound, pyridinoline, in urine as an index of collagen degradation in joint disease.

Authors:  S P Robins; P Stewart; C Astbury; H A Bird
Journal:  Ann Rheum Dis       Date:  1986-12       Impact factor: 19.103

9.  Cross-linking of collagen. Location of pyridinoline in bovine articular cartilage at two sites of the molecule.

Authors:  S P Robins; A Duncan
Journal:  Biochem J       Date:  1983-10-01       Impact factor: 3.857

10.  Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography.

Authors:  D R Eyre; T J Koob; K P Van Ness
Journal:  Anal Biochem       Date:  1984-03       Impact factor: 3.365
View more
  14 in total

Review 1.  Diagnostic biomarkers for oral and periodontal diseases.

Authors:  Mario Taba; Janet Kinney; Amy S Kim; William V Giannobile
Journal:  Dent Clin North Am       Date:  2005-07

2.  Galactosylhydroxylysine and pyridinium cross links in monitoring the bone response to hormone replacement therapy.

Authors:  R Marabini; P Sirtori; R Chionna; L Barzizza; A Rubinacci
Journal:  J Endocrinol Invest       Date:  1996-03       Impact factor: 4.256

3.  Urinary excretion of pyridinium crosslinks of collagen in patients with osteoporosis and the effects of bone fracture.

Authors:  A M McLaren; L D Hordon; H A Bird; S P Robins
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

4.  The determination of pyridinium crosslinks in urine and serum as a possible marker of cartilage degradation in rheumatoid arthritis.

Authors:  G Hein; S Franke; A Müller; E Bräunig; T Eidner; G Stein
Journal:  Clin Rheumatol       Date:  1997-03       Impact factor: 2.980

Review 5.  C-telopeptide pyridinoline cross-links. Sensitive indicators of periodontal tissue destruction.

Authors:  W V Giannobile
Journal:  Ann N Y Acad Sci       Date:  1999-06-30       Impact factor: 5.691

6.  Urinary and synovial pyridinium crosslink concentrations in patients with rheumatoid arthritis and osteoarthritis.

Authors:  L Sinigaglia; M Varenna; L Binelli; F Bartucci; M Arrigoni; R Ferrara; G Abbiati
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

7.  Urinary excretion of the pyridinium cross-links of collagen in systemic lupus erythematosus.

Authors:  Y Kipen; R Will; B J Strauss; E F Morand
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

8.  Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis.

Authors:  A K Gough; N F Peel; R Eastell; R L Holder; J Lilley; P Emery
Journal:  Ann Rheum Dis       Date:  1994-01       Impact factor: 19.103

9.  Reduction of urinary levels of pyridinoline and deoxypyridinoline and serum levels of soluble receptor activator of NF-kappaB ligand by etanercept in patients with rheumatoid arthritis.

Authors:  Kageyama Yasunori; Takahashi Masaaki; Nagafusa Tetsuyuki; Kobayashi Hayato; Nagano Akira
Journal:  Clin Rheumatol       Date:  2008-03-13       Impact factor: 2.980

10.  Evaluation of Salivary Levels of Pyridinoline Cross Linked Carboxyterminal Telopeptide of Type I Collagen (ICTP) in Periodontal Health and Disease.

Authors:  Debasish Mishra; Sivaram Gopalakrishnan; K V Arun; Tirunveli Saravanan Subu Kumar; Santosh Devanathan; Satya Ranjan Misra
Journal:  J Clin Diagn Res       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.